Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

Many reviewers say it's also helpful for post-surgery recovery, acid reflux, heartburn and GERD.

Sleep apnoea is a disorder where your breathing stops and starts while you sleep with serious health implications - but how ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

KBIA’s Rebecca Smith recently sat down with Dr. Mohammad Badran at the University of Missouri who studies sleep apnea to ...

LIVERPOOL, N.Y. (WSYR-TV) — Sleep apnea isn’t just something that affects older adults anymore. Experts say they’re seeing ...

DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As global healthcare evolves towards proactive, ...

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

Sleep apnea often goes untreated because it doesn’t look the way most people expect it to. Many imagine loud, disruptive snoring or dramatic gasping in the middle of the night. For many others, though ...

Early management of obstructive sleep apnea in patients with IPF could slow disease progression and improve outcomes.

Experts reveal symptoms that strike during nighttime rest and what those signs might mean for your health.